HomeREGN • NASDAQ
Regeneron Pharmaceuticals Inc
$959.92
After Hours:
$959.92
(0.00%)0.00
Closed: Mar 18, 4:02:51 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$964.47
Day range
$959.49 - $970.71
Year range
$684.81 - $998.33
Market cap
105.36B USD
Avg Volume
491.93K
P/E ratio
27.61
Dividend yield
-
Primary exchange
NASDAQ
CDP Climate Change Score
B
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
3.43B0.58%
Operating expense
737.20M12.74%
Net income
1.16B-3.13%
Net profit margin
33.77-3.68%
Earnings per share
11.86-5.57%
EBITDA
1.12B-12.61%
Effective tax rate
-1.05%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
10.84B40.07%
Total assets
33.08B13.23%
Total liabilities
7.11B8.50%
Total equity
25.97B
Shares outstanding
107.46M
Price to book
3.98
Return on assets
7.69%
Return on capital
8.91%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
1.16B-3.13%
Cash from operations
1.09B-36.64%
Cash from investing
-66.20M96.44%
Cash from financing
-446.10M-80.17%
Net change in cash
577.60M249.87%
Free cash flow
566.88M-57.43%
About
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
Founded
1988
Employees
13,450
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu